September 2, 2025Sep 2 Drug development software maker Certara, and biotechs such as Schrodinger and Recursion Pharmaceuticals are already using AI to predict how experimental drugs might be absorbed, distributed, or trigger toxic side effects. View the full article
Create an account or sign in to comment